Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study
Authors:
- Ingunn JohansenIJIngunn Johansen
- Milada Cvancarova SmåstuenMSMilada Cvancarova Småstuen
- Stine Torp LøkkebergSLStine Torp Løkkeberg
- Vendel Ailin KristensenVKVendel Ailin Kristensen
- Marte Lie HøivikMHMarte Lie Høivik
- Charlotte LundCLCharlotte Lund
- Bjørn OlsenBOBjørn Olsen
- Vibeke StrandeVSVibeke Strande
- Gert Huppertz-HaussGHGert Huppertz-Hauss
- Tone Bergene AabrekkTATone Bergene Aabrekk
- May-Bente BengtsonMBMay-Bente Bengtson
- Petr RicanekPRPetr Ricanek
Open Access
- 27 July 2023
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 23 (1) , 1-11
Abstract
Background: Patients with inflammatory bowel disease report multiple symptoms, but the relationships among co-occurring symptoms are poorly understood. This study aimed to examine the prevalence of symptoms and explore symptom clusters and possible associations between symptom clusters and socio-demographic and clinical variables in patients newly diagnosed with inflammatory bowel disease. Methods: The IBSEN III study is a prospective population-based inception cohort of patients with inflammatory bowel disease. This study used patient data from the three largest hospitals in the study catchment area. The Memorial Symptom Assessment Scale was used to assess the prevalence of symptoms. Symptom clusters were identified using principal component analysis. Possible associations between socio-demographic and clinical variables and symptom cluster membership were estimated using regression analysis. Results: Of the 573 patients (age, ≥18 years) diagnosed with inflammatory bowel disease, 350 (61.1%) completed the questionnaire (responders). Eleven symptoms were reported by >50% of the responders. The three most prevalent symptoms were bloating (84%), drowsiness (81%), and lack of energy (81%). Three symptom clusters were identified: psychological (56% of the patients), impaired energy (28%), and physical (16%) clusters. Multinomial regression analysis revealed that vitamin D deficiency was significantly associated with the impaired energy cluster (odds ratio=2.49, 95% confidence interval [1.00-6.2], p=0.05). Conclusions: We found high symptom prevalence in patients newly diagnosed with inflammatory bowel disease. Three distinct symptom clusters were identified, and the psychological cluster includes >50% of the patients. Vitamin D deficiency is the only factor associated with cluster membership, namely the impaired energy cluster.Keywords
This publication has 58 references indexed in Scilit:
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- Experiences of patients with chronic gastrointestinal conditions: in their own wordsHealth and Quality of Life Outcomes, 2012
- Common Symptoms and Stressors Among Individuals With Inflammatory Bowel DiseasesClinical Gastroenterology and Hepatology, 2011
- Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One YearGastroenterology Research and Practice, 2011
- Chronic fatigue is associated with impaired health‐related quality of life in inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2010
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2009
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- A simple clinical colitis activity indexGut, 1998
- The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distressEuropean Journal of Cancer, 1994
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980